| Pharmacovigilance is a big deal these days. With | | | | Is it user-friendly? |
| companies bringing drugs to the market at the drop | | | | It is great to go in for a tech-savvy system but |
| of a hat and regulatory bodies setting up stringent | | | | keep in mind that the system must also be |
| rules on drug safety standards, an effective | | | | user-friendly. Make sure that the system is |
| pharmacovigilance system is a necessity for most | | | | uncomplicated. Your employees must be able learn to |
| drug manufacturers. | | | | use the system very quickly and with great ease. |
| Today, regulatory authorities demand greater | | | | Does it streamline case processing? |
| transparency during pre-marketing and | | | | Your pharmacovigilance must make managing and |
| post-marketing of each drug. It's also imperative that | | | | accessing data a whole lot easier. Choose a system |
| drug companies record and manage data on each and | | | | that ensures a smooth work flow and streamlines |
| every aspect of the drug manufacturing and | | | | your processing of individual cases. |
| marketing process because pharmaceutical risk | | | | Does it offer greater risk management? |
| management policies are getting tighter by the day. | | | | The core idea behind pharmacovigilance is effective |
| So, it pays to invest in an effective and efficient | | | | and early risk management. So, your system must be |
| pharmacovigilance system as it works to benefit the | | | | equipped to monitor, assess and detect drug risks as |
| drug manufacturer greatly in the long run. Before | | | | early as possible in order to avoid huge losses in |
| choosing a pharmacovigilance system, find out if the | | | | terms of finances, manpower, time and patient health |
| system answers to these questions favorably. | | | | in the later stages. |
| Is the pharmacovigilance system technologically | | | | Does it comply with global reporting standards? |
| advanced? | | | | Most drugs are developed for the global market. So, |
| Pharmacovigilance involves dealing with volumes and | | | | your pharmacovigilance system must also adhere to |
| volumes of data on a day-to-day basis. Make sure | | | | global adverse drug event reporting standards or else |
| that the system you are about to invest in is | | | | you need to keep investing on different systems for |
| technologically advanced to handle all the information. | | | | different markets. Also, choose a system that |
| Look up for features that make your work a lot | | | | complies with the reporting standards of various |
| easier. It saves time and improves productivity. You | | | | regulatory bodies. |
| gain a lot in the long haul. | | | | |